Biotechnology Newswire
CaridianBCT Initiates Clinical Trial for Whole Blood Process with Mirasol(R) Pathogen Reduction Technology
LAKEWOOD, Colo.-(Business Wire)-October 5, 2008 - CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it has initiated a clinical trial for...
Introgen Receives Notification from Nasdaq
AUSTIN, Texas-(Business Wire)-October 3, 2008 - Introgen Therapeutics, Inc. (NASDAQ:INGN), a developer of targeted molecular therapies for cancer, today announced that on September 29, 2008, it received a letter from The Nasdaq Stock Market ("Nasdaq") indicating that during the preceding 30...
Critical Therapeutics, Inc. Announces Effectiveness of Registration Statement for the Proposed Merger with Cornerstone BioPharma Holdings, Inc.
LEXINGTON, Mass.-(Business Wire)-October 3, 2008 - Critical Therapeutics, Inc. (NASDAQ: CRTX) announced today that the Securities and Exchange Commission, or the SEC, has declared effective its Registration Statement on Form S-4 containing the Proxy Statement/Prospectus relating to the previously...
Oscient Pharmaceuticals Receives NASDAQ Notice
WALTHAM, Mass.-(Business Wire)-October 3, 2008 - Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today received notification from the Listings Qualifications Department of The NASDAQ Stock Market LLC that, as of October 2, 2008, the Company's market value of publicly held shares ("MVPHS") had...
York Pharma Plc Announces The Acquisition Of Leading Dermatological & Wound Care Brands
HITCHEN, England-(Business Wire)-October 3, 2008 - York Pharma Plc (AIM: YRK) announces the acquisition of the worldwide commercial rights to two leading skin care and wound healing products. At the same time the company has raised $51.2 million to finance the product acquisition and support...
Amgen Appoints Francois de Carbonnel to the Company's Board of Directors
THOUSAND OAKS, Calif.-(Business Wire)-October 3, 2008 - Amgen (NASDAQ:AMGN) announced today that its Board of Directors has appointed Francois de Carbonnel to the Company's Board. Mr. de Carbonnel, 61, is a consultant and corporate financial advisor. He is also chairman of the board of Thomson...
Canon U.S.A. Showcases the CR-1 Non-Mydriatic Digital Retinal Camera at Vision Expo West
LAS VEGAS-(Business Wire)-October 3, 2008 - At Vision Expo West, Canon U.S.A., Inc., a leader in digital imaging solutions, will showcase its CR-1 Non-Mydriatic Digital Retinal Camera and its complete line of total digital imaging and workflow management solutions for eyecare professionals, in booth...
Microfluidics Nanotechnology Expert to Speak at National Nano Engineering Conference in Boston November 12-13
NEWTON, Mass.-(Business Wire)-October 3, 2008 - Microfluidics, a division of Microfluidics International Corporation (OTCBB: MFLU), has announced that the company's CTO and nationally renowned nanotechnology applications expert, Thomai (Mimi) Panagiotou, Ph.D, will be presenting a talk at the 2008...
A Pink Hummer, Pink Carpet and 12 Women on a Mission
WILLIAMSBURG, Va.-(Business Wire)-October 3, 2008 - They'll be arriving in a hot pink Hummer, strolling out onto a hot pink carpet and escorted by a colorful Good Health Fairy - all to kick-off the 2nd annual Pink Carpet Event premiering the "2009 A Calendar to Live By." Produced by a group of young...
Company Profile for Interrad Medical
-(Business Wire)-October 3, 2008 - Interrad Medical, Inc. is a developer, manufacturer and marketer of medical devices, designed for minimally-invasive interventional and surgical procedures. Interrad Medical has developed a new subcutaneous catheter securement system called SecurAcath. The...
Biomet, Inc. Reschedules Fiscal Year 2009 First Quarter Release and Conference Call
WARSAW, Ind.-(Business Wire)-October 3, 2008 - Biomet, Inc. announced today that it has rescheduled its Fiscal 2009 First Quarter release and first quarter conference call to Friday, October 10, 2008. The call will take place at 1:00 p.m. Eastern. The dial-in numbers will remain the same...
The EuroBiO 2008 "Call For Change Report"
PARIS-(Business Wire)-October 3, 2008 - EuroBiO 2008, (www.eurobio2008.com), THE Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congres conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive. During...
New Publication Shows Cleviprex(TM) Provides More Precise Blood Pressure Control in Cardiac Surgery Patients
PARSIPPANY, N.J.-(Business Wire)-October 3, 2008 - The Medicines Company (NASDAQ: MDCO) today announced that ECLIPSE, the largest safety program to date comparing intravenous antihypertensive therapies, has been published in the October issue of Anesthesia and Analgesia. Results show Cleviprex(TM...
Micronics Receives Continuation Grant from TATRC to Further Develop Its Rapid Blood Typing Test
REDMOND, Wash.-(Business Wire)-October 3, 2008 - Micronics, Inc. today announced that it has been awarded a continuation from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC) to support the ongoing development of a microfluidics-based test for efficiently screening...
Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
SANTA CLARA, Calif.-(Business Wire)-October 3, 2008 - Affymetrix Inc. (Nasdaq:AFFX) announced today that the PhyloChip, a custom Affymetrix microarray developed by Lawrence Berkeley National Laboratory, won the bronze prize in the 2008 Wall Street Journal Technology Innovation Awards. The...
Natus Medical Completes Acquisition of NeuroCom International
SAN CARLOS, Calif.-(Business Wire)-October 3, 2008 - Natus Medical Incorporated (Nasdaq:BABY) today announced that it has completed its acquisition of privately held NeuroCom International, Inc. NeuroCom, based in Clackamas, Oregon, develops and markets computerized systems for the assessment and...
Who's Developing What in Global Biopharmaceuticals? Read This Assessment of 50 Leading Companies and Discover the Latest Research and Performance
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets has announced the addition of the "Who's Developing What in Global Biopharmaceuticals?" report to their offering. A critical assessment of 50 leading companies, their research, products, partners and performance. The...
An Essential Report on Diagnostic Imaging Agents - Discover the Next Generation of New Contrast Agents to Detect Metabolic Changes at the Molecular Level
DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets and commercial research programs. The potential for the next generation of diagnostic imaging agents is significant. SPECT and PET tracers have been developed to measure oxidative metabolism, fatty acid and amino acid...
Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
SCHLIEREN/BASEL, Switzerland & SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 3, 2008 - Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint...
Minerva Biotechnologies Announces Major Stem Cell Breakthrough
BOSTON-(Business Wire)-October 3, 2008 - Minerva Biotechnologies, a leading nanotechnology, cancer and stem cell development company today announced a major breakthrough in stem cell research. Minerva and collaborators at the University of California at Santa Barbara discovered that a single, new...
Invitrogen Sets Third Quarter Earnings Release Date for Tuesday, October 21, 2008
CARLSBAD, Calif.-(Business Wire)-October 2, 2008 - Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, will announce its third quarter 2008 earnings on Tuesday, October 21, 2008, after Market close. Following the...
Repros Therapeutics Inc. Announces Closing of Previously Announced Direct Registered Offering
THE WOODLANDS, Texas-(Business Wire)-October 2, 2008 - Repros Therapeutics Inc. (NasdaqGM:RPRX) today announces that it has consummated its previously announced sale of an aggregate of 2.4 million shares of its common stock resulting in net proceeds to the Company of approximately $15.5 million...
District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
THOUSAND OAKS, Calif.-(Business Wire)-October 2, 2008 - Amgen (NASDAQ:AMGN) announced today that the United States (U.S.) District Court in Boston issued its written decision upholding the prior jury verdict and court rulings regarding the infringement, validity and enforceability of 10 claims of...
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 2, 2008 - Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
BIO Lauds Senate Passage of Strengthened Two-Year R&D Credit
WASHINGTON-(Business Wire)-October 2, 2008 - The Biotechnology Industry Organization (BIO) today lauded U.S. Senate passage of a 2-year extension of the federal research and development (R&D) tax credit and urged the House to pass the package when it is considered on Friday. The R&D tax credit...
Tech Council of Maryland Conference Attendees Vote Obama Energy Plan as "Most Green"
BETHESDA, Md.-(Business Wire)-October 2, 2008 - The Tech Council of Maryland, representing more than 525 companies in the nation's second-largest technology hub, held their first Clean and Green Technology Conference held at the Hyatt Regency in Bethesda, MD. At the Clean and Green Technology...
Final Call to Register for BioPartnering Europe (BPE)
LONDON-(Business Wire)-October 2, 2008 - There are now just ten days to go until this year's BioPartnering Europe which will be held on 12th-14th October, 2008 at the Queen Elizabeth Conference Centre in London, UK. With nearly 1200 delegates from Europe, the US and Asia now registered to attend...
Exelixis Files IND Application for XL888
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 2, 2008 - Exelixis, Inc. (Nasdaq:EXEL) announced today that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for XL888, a novel anticancer compound. XL888 is an orally available small...
Response Genetics, Inc. to Present at the Maxim Group Growth Conference
LOS ANGELES-(Business Wire)-October 2, 2008 - Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sales of molecular diagnostic tests for cancer, today announced that its management will present at the Maxim Group Growth Conference in New York on Oct. 7. The conference...
PPD Announces Third Quarter 2008 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C.-(Business Wire)-October 2, 2008 - PPD, Inc. (NASDAQ:PPDI) will release its third quarter 2008 financial results on Tuesday, October 21, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business Wire. On...
"Adventures of Ana L'Tech" Viral Video Gains Global Audience
NEWARK, Del.-(Business Wire)-October 2, 2008 - "The Adventures of Ana L'Tech" — a 6 minute video that mixes science and fun with not-so-subtle Monty Python references - has been viewed more than 10,000 times in at least 115 countries. The video, produced by Analtech, Inc. - the only U.S...
Orthofix International Receives 510(k) Approval For Next Generation Lumbar Fixation System
BOSTON-(Business Wire)-October 2, 2008 - Orthofix International N.V. (NASDAQ: OFIX) (the Company), announced today it has received 510(k) approval from the FDA for its next generation Firebird(TM) Spinal Fixation System. Firebird is a comprehensive system with a modular screw designed to provide...
Cubist Pharmaceuticals to Announce Third Quarter 2008 Financial Results on Thursday, October 16, 2008
LEXINGTON, Mass.-(Business Wire)-October 2, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its third quarter 2008 financial results at 4:00 p.m. EDT on Thursday, October 16th, 2008. In connection with this announcement, Cubist will host a conference call and live audio webcast (with...
Standard & Poor's Initiates Factual Stock Report Coverage on Mymetics Corporation
NEW YORK-(Business Wire)-October 2, 2008 - Standard & Poor's announced today that it has commenced Factual Stock Report coverage on Mymetics Corporation. Mymetics Corporation (OTCBB:MYMX), is a biotechnology company focused on developing prophylactic vaccines, presently focusing on vaccines...
CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology
AARHUS, Denmark-(Business Wire)-October 2, 2008 - Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in...
Provectus Lead Investigator Professor John F. Thompson Presents at "Perspectives in Melanoma XII" Conference
KNOXVILLE, Tenn.-(Business Wire)-October 2, 2008 - Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that the lead investigator for its Phase 2 melanoma study, Professor John F Thompson, MD, today presented clinical data...
CLSI Publishes Guideline for Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine
WAYNE, Pa.-(Business Wire)-October 2, 2008 - Reference materials are an important requisite for assuring reliable laboratory measurements and appropriate patient care. To ensure that a reference material is suitable for its intended purpose, its commutability characteristics need to be assessed in a...
Stentys appoints Michael D. Lesh, MD, as a Director
PARIS-(Business Wire)-October 2, 2008 - Stentys balloon inflation disconnects the mesh and creates an opening into the side branch lumen—Stentys' self-expanding property allows the in situ modeling of the stent to fit the patient's unique arterial anatomy. About Stentys Stentys intends to...
Indiana's Science Education Reform Gains Financial Boost and Brain Power from Eli Lilly and Company
INDIANAPOLIS-(Business Wire)-October 2, 2008 - According to the Indiana Department of Workforce Development's "Hoosier Hot 50 Jobs", Indiana workers will be needed to fill more than 46,000 new jobs related to the science, technology, engineering and mathematics (STEM) disciplines (health care...
Sadra Medical Announces Patient Enrollment in European Feasibility Study of the Lotus(TM) Valve System
CAMPBELL, Calif.-(Business Wire)-October 2, 2008 - Sadra Medical, a medical device firm dedicated to developing innovative new therapies for aortic valve disease, today announced the enrollment and treatment of four new patients in the second phase of its European Feasibility Study of the Sadra...
CDISC Interchange Promises New Views into Healthcare's Interoperability with Medical Research
AUSTIN, Texas-(Business Wire)-October 2, 2008 - The Clinical Data Interchange Standards Consortium (CDISC) announced today an authoritative line up of keynote speakers and the promise of a robust information exchange forum at this year's CDISC International Interchange (26-31 October 2008). The...
NeuroMetrix Receives FDA 510(k) Clearance for UNIVERSAL(TM) Electrodes used in the Performance of Nerve Conduction Studies
WALTHAM, Mass.-(Business Wire)-October 2, 2008 - NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has received 510(k) clearance for its UNIVERSAL Electrodes from the U.S. Food and Drug Administration (FDA). This regulatory determination by the FDA gives NeuroMetrix clearance to market the...
Q Pharma, Inc. Launches iValidate 2.0
MORRISTOWN, N.J.-(Business Wire)-October 2, 2008 - Q Pharma, Inc., the industry leader in FDA Regulatory and Compliance Solutions, announced today the official release of their online practitioner validation application, iValidate(TM) 2.0. This tool assists Pharmaceutical and Biotechnology companies...
Genta Announces Webcast of 2008 Annual Shareholders Meeting
BERKELEY HEIGHTS, N.J.-(Business Wire)-October 2, 2008 - Genta Incorporated (OTCBB: GNTA) announced that the Company will host a conference call and live audio webcast of its 2008 Annual Meeting of Shareholders. The meeting will be held on Monday, October 6, 2008 at 11:00 a.m., EDT at the...
ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197
WOBURN, Mass.-(Business Wire)-October 2, 2008 - ArQule, Inc. (NASDAQ: ARQL) today announced the expansion of its Phase 2 trial with ARQ 197, a proprietary, orally administered small molecule inhibitor of the c-Met receptor tyrosine kinase, in MiT (Microphthalmia Transcription Factor)-associated...
Nextrials Positions Strategic Sales Force Across the U.S. for Improved Customer Access and Service
SAN RAMON, Calif.-(Business Wire)-October 2, 2008 - Nextrials, Inc., (www.nextrials.com) a leader in clinical research software and services, today announced the addition of regional directors of business development to its sales force. Scott Steward, based in Texas, and Virginia (Giga) Smith, based...
Celldex Receives $10 Million Milestone Payment
NEEDHAM, Mass.-(Business Wire)-October 2, 2008 - Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that it has received a milestone payment of $10,000,000 from an affiliate of Paul Capital Healthcare (PCH). The payment was triggered by the market launch of Rotarix(R) in the United States...
Progenics Announces Progress and Presentations in HIV Therapy Program
TARRYTOWN, N.Y.-(Business Wire)-October 2, 2008 - Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the completion of enrollment in two, phase 2 clinical studies of PRO 140, an investigational drug that is being developed for treatment of human immunodeficiency virus (HIV) infection...
Biothera Develops New Method for Analyzing Beta Glucan Structure
EAGAN, Minn.-(Business Wire)-October 2, 2008 - Biothera has developed a new analytical method to characterize a key structural attribute of beta 1,3/1,6 glucans, which will aid researchers developing this immune-enhancing carbohydrate for pharmaceutical applications. The method was presented...
Bristol-Myers Squibb Appoints Christopher Perley as Devens General Manager
DEVENS, Mass.-(Business Wire)-October 2, 2008 - Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Perley has been named vice president and general manager of its Devens biologics manufacturing facility. In this role, Perley will be responsible for continuing the supervision of...
Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference
COLUMBIA, Md.-(Business Wire)-October 2, 2008 - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that C. Randal Mills...
Physicians Interactive Acquired by Private Investment Firm Perseus L.L.C.
CHICAGO & WASHINGTON-(Business Wire)-October 2, 2008 - Physicians Interactive, the leading provider of emarketing solutions for pharmaceutical, biotech and medical device companies, announced it has been acquired by a fund that is managed by Perseus, L.L.C. from Allscripts Healthcare...
Roche Diagnostics Extends License for Universal ProbeLibrary (UPL) Kits from Exiqon A/S
PENZBERG, Germany-(Business Wire)-October 2, 2008 - Roche Diagnostics and Exiqon A/S, Vedbaek, Denmark, a provider of high-value gene expression analysis products, today announced the signing of an amendment to their 2005 license and distribution agreement for the Universal ProbeLibrary (UPL) that...
Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding
VILLA GUARDIA, Italy-(Business Wire)-October 2, 2008 - Gentium S.p.A. (NASDAQ: GENT) (the "Company") today announced that the Court of Como issued a decision terminating the legal proceeding brought in August against the Company's Board of Directors and Board of Statutory Auditors. The proceeding...
StemCells, Inc. Receives NIH Grant to Pursue Cell-Based Therapeutic for Hepatitis C
PALO ALTO, Calif.-(Business Wire)-October 2, 2008 - StemCells, Inc. (Nasdaq:STEM) announced today that it has been awarded a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapeutic for liver disease arising...
Examine the Who, What, When, Where of Biotechnology R&D with This Pipeline News Report - Therapeutic Area Edition
DUBLIN, Ireland-(Business Wire)-October 2, 2008 - Research and Markets ; - Technology News; - R&D Collaboration Deals; - R&D Licensing Deals; - Mergers & Acquisitions For more information visit http://www.researchandmarkets.com/research/246b38/rd_pipeline_news
GenVec Receives Third-Year Funding from NIAID for HIV Vaccine Contract
GAITHERSBURG, Md.-(Business Wire)-October 2, 2008 - GenVec, Inc. (Nasdaq:GNVC) announced today that the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), has executed its second option period (year three) under a previously announced...
Presidio Pharmaceuticals, Inc. to Present at the JMP Securities and BioPartnering Europe Healthcare Conferences
SAN FRANCISCO-(Business Wire)-October 2, 2008 - Presidio Pharmaceuticals, Inc. announced today that Mr. Leo Redmond, Chief Financial Officer at Presidio will be presenting an overview of Presidio and an update to its HCV and HIV programs at the Third Annual JMP Securities Healthcare Focus Conference...
Report: Health Care Quality Improves but Varies Across Different Regions of the Country
WASHINGTON-(Business Wire)-October 2, 2008 - The quality of health care for millions of Americans improved in 2007 but significant variations in performance continue to leave many people receiving substandard care, according to a report released today by the National Committee for Quality...
ImClone Systems Issues Statement
NEW YORK-(Business Wire)-October 2, 2008 - Carl Icahn, Chairman of the Board of ImClone Systems Incorporated (NASDAQ: IMCL), stated that the large Pharma company has completed due diligence and made a proposal not subject to financing or further due diligence. Negotiations between the parties are...
Kuopio University Hospital in Finland Adopts ZOLL AutoPulse Non-invasive Cardiac Support Pump
CHELMSFORD, MASS.-(Business Wire)-October 1, 2008 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that the Kuopio University Hospital (KUH), one of the largest hospitals in Finland, has successfully implemented the...
Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
OOSTERHOUT, The Netherlands-(Business Wire)-October 1, 2008 - Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the agenda for Planet xMAP Europe 2008, the company's annual European multiplexing technology symposium, which will be held 8-9 October, at...
U.S. Food & Drug Administration Approved the use of REYATAZ(R) (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
PRINCETON, N.J.-(Business Wire)-October 1, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food & Drug Administration (FDA) approved the use of REYATAZ(R) (atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as part of combination therapy in...
JMP Securities Healthcare Conference to Be Held in New York
SAN FRANCISCO-(Business Wire)-October 1, 2008 - JMP Group Inc. (NYSE:JMP), an investment banking and alternative asset management firm, announced today that its broker-dealer subsidiary, JMP Securities, will host the third annual JMP Securities Healthcare Focus Conference at Le Parker Meridien in...
Mysterious Snippets of DNA Withstand Eons of Evolution, Stanford Study Finds
STANFORD, Calif.-(Business Wire)-October 1, 2008 - Small stretches of seemingly useless DNA harbor a big secret, say researchers at the Stanford University School of Medicine. There's one problem: We don't know what it is. Although individual laboratory animals appear to live happily when these...
Syprosoft Engineering to Develop Image Processing Software for Applied BioCode
IRVINE, Calif.-(Business Wire)-October 1, 2008 - Syprosoft Engineering announced today that it has been retained by Applied BioCode, Inc. to help develop their Digital Magnetic Bead technology in image processing for the medical diagnostics and bioresearch life sciences markets. "We were looking for...
PPD Completes Acquisition of InnoPharm
WILMINGTON, N.C.-(Business Wire)-October 1, 2008 - PPD, Inc. (Nasdaq: PPDI) today announced it has completed the acquisition of InnoPharm, an independent contract research organization based in Smolensk, Russia, strengthening its ability to offer Phase II-IV clinical trials support, data...
ETLT Management Announcement
HOUSTON-(Business Wire)-October 1, 2008 - Eternal Technologies Group, Inc. (OTCBB:ETLT) today announced that the reason of the Company's symbol with Q is caused by the lawsuit with WESTERN SECURITIES. But it doesn't impact the company's financial and operation situation. Company is still under the...
Vertex Pharmaceuticals Announces Webcast of its Presentation at the JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 9:30 a.m. EDT. The presentation will be webcast live...
Exelixis Announces October 6 Webcast of Presentation at the JMP Securities 3rd Annual Healthcare Focus Conference
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-October 1, 2008 - Exelixis, Inc. (Nasdaq:EXEL) announced today that George A. Scangos, PhD, President and Chief Executive Officer of Exelixis, will present at the JMP Securities 3rd Annual Healthcare Focus Conference at 11:30 a.m. ET/8:30 a.m. PT on...
H&Q Life Sciences Investors Pays Stock Distribution
BOSTON-(Business Wire)-October 1, 2008 - On September 30, 2008, H&Q Life Sciences Investors paid a stock distribution of $0.26 per share. Of the eligible shares, 48% opted to receive stock. The new shares were issued at a share price of $10.82 and 21,084,815 shares are now outstanding. This...
Alnylam to Webcast Presentation at The Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at The Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008, at 1:30...
7th Annual Charlotte Biotechnology Conference to feature Dr. Roger Newton, co-discoverer of Lipitor(R) and founder of Esperion Therapeutics, Inc.
CHARLOTTE, N.C.-(Business Wire)-October 1, 2008 - The University of North Carolina at Charlotte and the Charlotte Research Institute will present the 7th Annual Charlotte Biotechnology Conference (www.CharlotteBiotechnology.com) taking place at the Barnhardt Student Activities Center on October...
SAFE-BioPharma Announces Fast, Innovative Identity Proofing Procedure
FT. LEE, N.J.-(Business Wire)-October 1, 2008 - SAFE-BioPharma Association today announced the launch of an innovative, simple, and exceptionally fast procedure for identity proofing and authenticating individuals being equipped with medium assurance digital certificates. The procedure, which...
Patient Safety and Incentives for Continued Innovation Must be Provided in Any Pathway for the Approval of Follow-On Biologics, BIO Tells FTC
WASHINGTON-(Business Wire)-October 1, 2008 - Patient safety and data exclusivity to preserve biomedical innovation should stand at the center of a regulatory approval pathway for follow-on biologics, wrote the Biotechnology Industry Organization (BIO) in comments provided yesterday to the Federal...
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes
MELVILLE, N.Y.-(Business Wire)-October 1, 2008 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its 2% Convertible Senior Notes due 2025 (the "notes") are now convertible at the option of the holders and will remain convertible through December 31, 2008, the last trading day of the...
2008 Mid-Atlantic Bio to be Held October 22-24, 2008
CHANTILLY, Va.-(Business Wire)-October 1, 2008 - Mid-Atlantic Bio: -0- *T WHO...
BIOTECHNICA 2008 to Feature Cornucopia of Cutting-Edge Topics
HANNOVER, Germany-(Business Wire)-October 1, 2008 - Whether it involves new medicines for cancer, innovative vaccines, new plant varieties, energy-saving detergents or genetic fingerprints, biotechnology has become en established fixture in our lives. Running from 7 to 9 October, Europe's biggest...
BIOTECHNICA Promotes Dialogue on European Biotech Goals
HANNOVER, Germany-(Business Wire)-October 1, 2008 - Modern biotechnology plays a vital role in many areas of our lives, including healthcare, food production, manufacturing industry and environmental protection. Yet ethical issues such as the use and control of genetic data continue to generate...
A Two-Day Investment and Management Conference for Neurotechnology Entrepreneurs and Executives: October 23-24, 2008
DUBLIN, Ireland-(Business Wire)-October 1, 2008 - Research and Markets has announced the addition of the "The Eighth Annual Neurotech Leaders Forum" conference to their offering. Eighth Annual Neurotech Leaders Forum Radisson Hotel San Francisco Airport, Brisbane, CA This two-day conference offers...
Arriva Pharmaceuticals Granted Protein Production Patent
ALAMEDA, Calif.-(Business Wire)-October 1, 2008 - Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced today that it had been granted a patent in the U.S. for methods to produce certain proteins in yeast. Among the proteins whose production...
Agilent Technologies Creates Specialized Training Program in China for Melamine Analysis in Milk, Milk Products
SANTA CLARA, Calif.-(Business Wire)-October 1, 2008 - Agilent Technologies Inc. (NYSE:A) announced today it has created a specialized training program to address the current melamine crisis in China. The program will be available in early October and is part of Agilent University, a multifaceted...
Inotek Appoints Paul G. Howes as President and CEO
BEVERLY, Mass.-(Business Wire)-October 1, 2008 - Inotek Pharmaceuticals Corporation announced today that it has hired Paul G. Howes as President, CEO and Director. Mr. Howes brings more than twenty years of senior level pharmaceutical experience to Inotek, most recently serving as President of the...
US Centers for Disease Control and Prevention Expands Golden Helix License
BOZEMAN, Mont.-(Business Wire)-October 1, 2008 - Golden Helix, Inc., the global leader in genetic association software, today announced that the US Centers for Disease Control and Prevention (CDC) has expanded its licensing agreement for the Golden Helix SNP and Variation Suite. While the CDC has...
Meridian Bioscience to Present at the William Blair and Company Small-Cap Growth Stock Conference
CINCINNATI-(Business Wire)-October 1, 2008 - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that the Company has been invited to present at the William Blair and Company Small-Cap Growth Stock Conference on Tuesday, October 7, 2008 at 12:00 p.m. ET at the...
GenomeQuest Announces Integration of GenomeQuest(TM) 5.0 with Invitrogen's Vector NTI Advance(TM) for Genomic Sequence Analysis
WESTBOROUGH, Mass.-(Business Wire)-October 1, 2008 - GenomeQuest and Invitrogen today announced that the GenomeQuest(TM) 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen's Vector NTI Advance(TM) desktop sequence analysis solution. Ronald...
NovaBay Pharmaceuticals to Present at the Maxim Group Annual Growth Conference
EMERYVILLE, Calif.-(Business Wire)-October 1, 2008 - Dr. Ron Najafi, CEO of NovaBay Pharmaceuticals, Inc. (AMEX: NBY & TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of...
Taconic and Samaritan Pharmaceuticals Announce Availability of New Rat Model to Study Alzheimer's Disease
HUDSON, N.Y.-(Business Wire)-October 1, 2008 - Taconic, one of the largest laboratory rodent providers in the world, together with Samaritan Pharmaceuticals, Inc. (OTC BB:SPHC.OB - News), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced the...
Dicerna Pharmaceuticals Announces Preclinical Findings Highlighting Novel Approach to Maximizing Dicer-Substrate Small Interfering RNAs (DsiRNAs) in Rheumatoid Arthritis; Data Appear Published by Molecular Therapy
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), announced today a paper appearing in the advance online publication...
Phase Forward to Present at the William Blair Small Cap Growth Stock Conference
WALTHAM, Mass.-(Business Wire)-October 1, 2008 - Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will...
RegeneRx to Develop RGN-457 for Cystic Fibrosis
BETHESDA, Md.-(Business Wire)-October 1, 2008 - REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (TB4...
Bio-Matrix Scientific Group, Inc. Receives and Processes First Cord Blood Specimens as Part of the Company's Quality Assurance Program
SAN DIEGO-(Business Wire)-October 1, 2008 - Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced today that they have received and processed human umbilical cord blood units as part of their long-term liquid...
Aeolus Pharmaceuticals Receives $175,000 Milestone Payment From Cardiovascular Company
LAGUNA NIGUEL, Calif.-(Business Wire)-October 1, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has received a milestone payment from ARCA Biopharma, Inc., a privately held cardiovascular-focused company ("ARCA"). In 2003, CPEC, LLC ("CPEC"), a limited liability company...
Thirteen Advocacy Groups Collaborate on New Online Resource Dedicated to Patients with Advanced Breast Cancer
NEW YORK-(Business Wire)-October 1, 2008 - Today, those living with advanced breast cancer now have an online resource available specifically for them. AdvancedBreastCancerCommunity.org is the first comprehensive online resource to serve as a clearinghouse of information for those impacted by...
Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets (Ehrlich II) in Nurnberg, Germany
SASSARI, Italy & PRINCETON, N.J.-(Business Wire)-October 1, 2008 - ViroStatics, srl today announced the Company's President and CEO, Dr. Franco Lori, will be speaking at the prestigious 2nd World Conference on Magic Bullets (Ehrlich II) in Nurnberg, Germany on Saturday, October 4th 2008. Dr...
Key Findings from Unique Sex and Gender Symposium Help Advance the Development of Sex-Specific Medical Technology for Treating Vascular Diseases
BLOOMINGTON, Ind.-(Business Wire)-October 1, 2008 - The "Impact of Sex and Vascular Diseases and Implications for Therapies" symposium uncovered a series of knowledge gaps related to the sex differences in vascular disease, its symptoms, risk factors and response to treatment. Conference...
Aptuit Launches Program to Accelerate Early Stage Drug Development
GREENWICH, Conn.-(Business Wire)-October 1, 2008 - Aptuit Inc. announced today the launch of a new program to accelerate early stage drug development. Aptuit INDiGO(TM) is a fully customizable program that offers an accelerated track from preclinical candidate selection to regulatory submission...
Allos Therapeutics to Present at the JMP Healthcare Focus Conference
WESTMINSTER, Colo.-(Business Wire)-October 1, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company's senior management will...
454 Life Sciences Launches the GS FLX Titanium Series Reagents, Effectively Replacing Traditional Sanger Sequencing
BRANFORD, Conn.-(Business Wire)-October 1, 2008 - 454 Life Sciences Corporation, a Roche company, announced the launch of the new GS FLX Titanium series reagents and software that are transforming the life science's industry. The new reagent kits provide individual sequencing reads with an...
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it has appointed John A. Schmidt, Jr., M.D. to the position of Chief Scientific Officer. In this role, Dr. Schmidt will play a critical role in...
Applied Biosystems Debuts New SOLiD(TM) 3 System Expected to Enable $10K Genome
FOSTER CITY, Calif.-(Business Wire)-October 1, 2008 - Applied Biosystems (NYSE:ABI) today announced a new genomic analysis platform, the SOLiD(TM) 3 System, that is expected to enable scientists to sequence a human genome for approximately $10,000. Significant cost-reduction and productivity...
Geron Supports Governor's Veto of SB1565
MENLO PARK, Calif.-(Business Wire)-October 1, 2008 - Geron Corporation (Nasdaq:GERN) today announced support for California Governor Arnold Schwarzenegger's veto of Senate Bill 1565. The proposed legislation would have implemented a number of changes counter to the original provisions of Proposition...
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.-(Business Wire)-October 1, 2008 - Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may...
Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear cell renal carcinoma...
Sirtris' Review of Sirtuin Therapeutics for Diseases of Aging in the Journal Nature Reviews Drug Discovery
CAMBRIDGE, Mass.-(Business Wire)-October 1, 2008 - Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to...
U.S. Government to Purchase Additional 14.5 Million Doses of BioThrax under New Contract Valued at up to $404 Million
ROCKVILLE, Md.-(Business Wire)-October 1, 2008 - Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a new, multi-year, firm fixed price contract with the U.S. Department of Health and Human Services (HHS) to supply an additional 14.5 million doses of BioThrax(R) (Anthrax...
PuriCore Raises $9.74 Million
MALVERN, Pa. & STAFFORD, England-(Business Wire)-October 1, 2008 - PuriCore plc (LSE:PURI), the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced that it has closed on...
Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2008
SAN JOSE, Calif.-(Business Wire)-October 1, 2008 - HighTech Business Decisions has just published its new study: Biopharmaceutical Contract Manufacturing: Best Practices Pricing Study 2008. This 300-page report documents current industry price and contract practices for biopharmaceutical contract...
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer
SCOTTSDALE, Ariz.-(Business Wire)-October 1, 2008 - Apthera, Inc. announced the optimized dose and schedule for its lead drug, NeuVax, in treating early-stage breast cancer patients to be used in Phase III clinical trials. Dr. George Peoples, Deputy Director, United States Military Cancer Center...
Cerus to Present at the JMP Securities Healthcare Conference
CONCORD, Calif.-(Business Wire)-October 1, 2008 - Cerus Corporation (NASDAQ: CERS) announced today that company management will present at the JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008 at 1:00pm EDT at Le Parker Meridien hotel in New York City. A live webcast will be...
Ore Pharmaceuticals Begins Clinical Trial of GL1001
GAITHERSBURG, Md.-(Business Wire)-October 1, 2008 - Ore Pharmaceuticals Inc. (NASDAQ: ORXE) announced today that it has initiated dosing subjects with GL1001, the Company's lead drug candidate, in a multiple ascending dose clinical trial. GL1001, the first clinical-stage inhibitor of the ACE2...
BIOTECHNICA 2008 Exhibitor Profiles
HANNOVER, Germany-(Business Wire)-October 1, 2008 - BIOTECHNICA 2008 takes place October 07, 2008 - October 09, 2008 at the Deutsche Messe Exhibition Grounds in Hannover, Germany. Listed below are the BIOTECHNICA 2008 exhibitor profiles. For in-depth information about BIOTECHNICA 2008, visit...
Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus (POI)
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-October 1, 2008 - Tranzyme Pharma today announced positive Phase IIb results for its first-in-class, highly potent and selective ghrelin agonist, TZP-101, for the management of postoperative ileus (POI). Results demonstrated that TZP-101 was both safe and...
Redsense Medical: Bayhealth Medical Center, Delaware, First to Use Redsense Alarm In US
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Redsense Medical has received its first US order from Bayhealth Medical Center, southern Delaware's largest healthcare system. The hospital will start using the Redsense blood loss detection device during hemodialysis. Redsense Medical is currently...
Biotage Divests Biosystems Division to QIAGEN
STOCKHOLM, Sweden-(Business Wire)-October 1, 2008 - Regulatory News: As a result of the Strategic Review of Biotage's (STO:BIOTA) entire operations, launched in October 2007, the Board of Biotage AB ("Biotage") has concluded to divest the Biosystems division ("Biosystems") and the shares in...
Activaero Cooperates with Bayer HealthCare in the Development of Inhaled Treatments
GEMUNDEN, Germany-(Business Wire)-October 1, 2008 - Activaero GmbH, the world leader in controlled breathing technologies for inhaled therapeutic agents, today announced a licensing and option agreement with Bayer HealthCare AG on the development of inhaled treatments. Under the terms of the...
Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology
THOUSAND OAKS, Calif.-(Business Wire)-September 30, 2008 - Amgen Inc., (NASDAQ: AMGN) announced it has received a summary of preliminary results from the Cochrane Collaboration's independent meta-analysis of patient-level data from previously conducted, randomized, controlled, clinical studies...
Biogen Idec to Report Third Quarter 2008 Financial Results on October 21, 2008
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Biogen Idec Inc. (NASDAQ: BIIB) today announced it will report third quarter 2008 financial results on Tuesday, October 21, 2008, before the financial markets open. Following the release of the financials, the Company will host a live webcast...
Celera to Webcast Presentation at Third Annual JMP Securities Healthcare Focus Conference
ALAMEDA, Calif.-(Business Wire)-September 30, 2008 - Celera Corporation (NASDAQ:CRA), announced today that it will webcast its presentation at the Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008. The live webcast is scheduled to begin at 11:30 a.m. ET. The...
Incyte to Present at JMP Securities Third Annual Healthcare Focus Conference
WILMINGTON, Del.-(Business Wire)-September 30, 2008 - Incyte Corporation (Nasdaq:INCY) announced today it will present at the JMP Securities Third Annual Healthcare Focus Conference on Monday, October 6, 2008 at 11:00 a.m. (Eastern Time). Paul Friedman, M.D., president and chief executive officer of...
Somaxon Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference and the Second Annual Natixis Hidden Gems Conference
SAN DIEGO-(Business Wire)-September 30, 2008 - Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) today announced that Richard Pascoe, the company's president and chief executive officer, will present a company update at the JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 8:30...
SurModics Acquires CodeLink(TM) Activated Slide Business
EDEN PRAIRIE, Minn.-(Business Wire)-September 30, 2008 - SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today the acquisition of the CodeLink(TM) Activated Slide microarray business from GE Healthcare...
Unigene Enters into Agreement for $20 Million Non-Convertible Debt Financing
BOONTON, N.J.-(Business Wire)-September 30, 2008 - Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) today announced that it has entered into a financing agreement for $20 million three-year non-convertible, senior secured term notes and up to 1,500,000 shares of Common Stock. Unigene...
AxoGen Awarded Accreditation from American Association of Tissue Banks
ALACHUA, Fla.-(Business Wire)-September 30, 2008 - AxoGen, Inc., a leader in the development of treatment options for the repair of peripheral nerve injuries, announced today that the American Association of Tissue Banks (AATB) has awarded them the prestigious AATB accreditation. This...
Idera Pharmaceuticals to Present at JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), a biopharmaceutical company focused on developing therapeutics targeting Toll-Like Receptors (TLR), today announced that it will discuss its TLR-targeted drug discovery and development programs and...
EuroBiO 2008 Is Pleased to Announce the Participation of Internationally Renowned Life Sciences Experts
PARIS-(Business Wire)-September 30, 2008 - EuroBiO 2008, (www.eurobio2008.com), THE Life Sciences Event of the EU Presidency awarded prestigious EU Presidency Label, will take place at the Palais des Congres conference centre in Paris from Tuesday, October 7th to Thursday, October 9th inclusive...
BIO Commends SEC Efforts to Combat Illegal "Naked" Short Selling
WASHINGTON-(Business Wire)-September 30, 2008 - The Biotechnology Industry Organization (BIO) today released its letter to SEC Chairman Christopher Cox and SEC Director Linda Thomsen commending the agency for its efforts to investigate fraud and crack down on activities such as rumor mongering and...
Novalyst Discovery and AliX Agree to Merge / NovAliX Launch
STRASBOURG, France-(Business Wire)-September 30, 2008 - Following long-standing cooperation, Novalyst Discovery, a chemistry services company, and AliX, a structural biology company, have agreed to merge to create a leading CRO. Together they have launched NovAliX, a multidisciplinary company...
Cook Medical Continues to Drive Endoscopy Innovations with Industry's Strongest 3 Stage Balloon Dilator
WINSTON-SALEM, N.C.-(Business Wire)-September 30, 2008 - Cook Medical continues to innovate in the endoscopy market with Hercules(TM), the strongest three-stage balloon dilator for benign and malignant strictures in the esophagus. The Endoscopy strategic business unit of Cook, offering the most...
Advaxis Incorporated's Board of Directors Approve Senior Promissory Note
NORTH BRUNSWICK, N.J.-(Business Wire)-September 30, 2008 - The Board of Directors of Advaxis Inc., (OTCBB: ADXS), a developmental biotechnology company, has approved, by majority vote, the motion to accept a senior promissory note (the "Note") from Advaxis Chairman & CEO Thomas Moore...
ZenBio, Inc. Awarded $1.38 Million Phase II SBIR Grant for Skeletal Muscle Program
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 30, 2008 - ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize their primary human skeletal myocyte and adipocyte co-culture system. The $1.38 million award from the National Institutes of Health will fund...
UMS Announces a New Mobile Brachytherapy Service for Ambulatory Surgery Centers
WESTBOROUGH, Mass.-(Business Wire)-September 30, 2008 - United Medical Systems, a mobile services company, is launching a new "turnkey" brachytherapy service program in selected areas of the United States. UMS is initiating this program based upon new rules and changes made in the reimbursement...
Metabolon and Syngenta Sign Expanded Research Agreement
RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 30, 2008 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today an expanded, multi-year agreement with Syngenta, a leading global agribusiness. Through this agreement, Syngenta will have access...
Take Care Health Systems Extends Presence in Tennessee with Locations in Knoxville and Memphis
CONSHOHOCKEN, Pa.-(Business Wire)-September 30, 2008 - Take Care Health Systems, one of the largest managers of convenient care clinics and a wholly-owned subsidiary of Walgreens (NYSE, NASDAQ: WAG), has opened locations in Knoxville and Memphis, joining the Nashville market which opened in late...
BIO-Europe 2008: World's Top Pharmaceutical Firms to Gather in Force Seeking Partnerships and Discovering New Ways to Enhance Deal Values
SAN DIEGO & WASHINGTON-(Business Wire)-September 30, 2008 - As partnering transactions continue at record-breaking rates and deals continue as the defining industry trend, the critical question confronting big pharma is not if they should embrace earlier stage deals, but how to best take...
CSL Behring Solicits Proposals for LEAD Grants to Support Patient Advocacy Efforts
KING OF PRUSSIA, Pa.-(Business Wire)-September 30, 2008 - CSL Behring, a global leader in the plasma protein biotherapeutics industry, is soliciting grants to support patient access to care through its Local Empowerment for Advocacy Development (LEAD) program. The LEAD program is committed to...
Pfizer Shows Accelerating Pipeline with Significant Growth in Late-Stage Clinical Development
NEW YORK-(Business Wire)-September 30, 2008 - Pfizer Inc today provided the latest update to its development pipeline, showing significant progress in achieving the company's growth, productivity and performance goals. The pipeline now includes 114 programs, from Phase 1 through Registration. The...
VaxInnate's Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009
CRANBURY, N.J.-(Business Wire)-September 30, 2008 - VaxInnate Corporation, a biotechnology company pioneering breakthrough technology to develop novel seasonal and pandemic influenza vaccines, today announced that its second influenza vaccine candidate has entered clinical development. The Phase I...
Survey Finds U.S. Biopharma Industry Is Moving Steadily Toward Secure Distribution
MANHASSET, N.Y. & PALO ALTO, Calif.-(Business Wire)-September 30, 2008 - Pharmaceutical Commerce and Blue Vector Systems today announced survey results reporting the U.S. biopharmaceutical industry's progress in adopting serialization and addressing related supply chain challenges. Conducted...
Cellumen Partners with Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
PITTSBURGH-(Business Wire)-September 30, 2008 - Cellumen, Inc. today announced an agreement with the Alzheimer's Drug Discovery Foundation (ADDF) to apply Cellumen's Cellular Systems Biology (CSB) technology to create a cellular model of Alzheimer's disease. The main objective of the partnership...
AMRI Appoints New Chemistry Director of European Operations
ALBANY, N.Y.-(Business Wire)-September 30, 2008 - AMRI (NASDAQ: AMRI) has named Gergely Makara, Ph.D. as director of chemistry for European operations. Dr. Makara will report to Philip Small, Ph.D. who was promoted from director of chemistry to managing director of AMRI's European operations in June...
Seattle Genetics Adds to Senior Management Team
BOTHELL, Wash.-(Business Wire)-September 30, 2008 - Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointments of Elaine Waller, PharmD to Senior Vice President, Regulatory Affairs and Christopher Pawlowicz to Senior Vice President, Human Resources, as well as the promotion of Jonathan...
Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development
SEATTLE-(Business Wire)-September 30, 2008 - Koronis Pharmaceuticals, Inc., a biotechnology company focused on the development of antiviral therapeutics, today announced that Courtney Fletcher, Pharm. D., will join the Company's Scientific Advisory Board and Jeff Parkins has been promoted to Vice...
Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS
LAGUNA NIGUEL, Calif.-(Business Wire)-September 30, 2008 - Aeolus Pharmaceuticals, Inc. (OTCBB: AOLS) announced today that it has initiated a follow-on Phase I open label compassionate use multiple dose study of AEOL 10150 in a patient diagnosed with progressive and debilitating amyotrophic...
GE Healthcare Acquires MicroCal Broadening Capabilities in Biomedical and Pharmaceutical Research
CHALFONT ST. GILES, England-(Business Wire)-September 30, 2008 - GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced it has acquired MicroCal LLC, a provider of innovative instruments for the study of molecular interactions in pharmaceutical, biomedical and life science...
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Link Medicine Corporation, a privately held biotechnology company advancing novel approaches for the treatment of neurodegenerative diseases, announced today that it has obtained $40 million of Series C equity financing to help move its lead...
Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies
CHAPEL HILL, N.C. & CHARLOTTESVILLE, Va.-(Business Wire)-September 30, 2008 - Cempra Pharmaceuticals, Inc., and Biovista, Inc., announced today that they have entered into a research agreement to systematically identify and profile adverse event associations for members of the macrolide drug...
AVEO Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008 at 3:00 p.m. (ET) at the Le...
Oxygen Biotherapeutics, Inc. to Present at Rodman & Renshaw Investment Conference in New York City on Nov. 12
COSTA MESA, Calif.-(Business Wire)-September 30, 2008 - Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced that company chairman and CEO Chris J. Stern, DBA will present at the Rodman & Renshaw Annual Global Investment Conference in New York on November 12, 2008 at 12:25 p.m. eastern...
Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU
BRIDGEWATER, N.J.-(Business Wire)-September 30, 2008 - Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced today that Oncaspar-IV(TM), the next generation pegylated L-asparaginase, received approval from the Commission of the European Communities for designation as an orphan medicinal product...
Synta Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference
LEXINGTON, Mass.-(Business Wire)-September 30, 2008 - Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the...
Acceleron to Present at Third Annual JMP Securities Healthcare Focus Conference
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a...
Advinus Therapeutics (P) Ltd. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Establish Drug Discovery and Development Collaboration
BANGALORE, India-(Business Wire)-September 30, 2008 - Advinus Therapeutics (P) Ltd., a TATA Enterprise has announced a drug discovery and development collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI). Under the agreement, Advinus and OMJPI have agreed to develop drug candidates...
Curis to Present at Maxim Group Growth Conference 2008
CAMBRIDGE, Mass.-(Business Wire)-September 30, 2008 - Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing next generation proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference 2008, which...
454 Life Sciences and GenomeQuest Team Up to Provide Next-Generation Sequence Search and Analysis Services
BRANFORD, Conn. & WESTBOROUGH, Mass.-(Business Wire)-September 30, 2008 - 454 Life Sciences, a Roche company, and GenomeQuest, Inc. announced a co-marketing agreement whereby GenomeQuest will offer its recently launched On-Demand Informatics Service to users of the 454 Genome Sequencer FLX...
ZIOPHARM Oncology to Present at Maxim Group Growth Investor Conference
NEW YORK-(Business Wire)-September 30, 2008 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Maxim Group Growth Investor Conference on Tuesday, October 7, 2008 at 3:30 pm ET in the Morosco room at the Grand Hyatt Hotel...
BioChemics, Inc. Announces Collaboration Agreement with Leading Light Based Technology Company
DANVERS, Mass.-(Business Wire)-September 30, 2008 - BioChemics, Inc. (BCI), a company "enhancing drug delivery through biophysical modulation," is pleased to announce the signing of a research collaboration agreement with Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of...
Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment
NEW YORK-(Business Wire)-September 30, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the first patient has been treated in its disease-directed Phase 2 clinical trial of IMC-1121B...
Spectrum Pharmaceuticals to Present at the JMP Securities Focus on Healthcare Conference
IRVINE, Calif.-(Business Wire)-September 30, 2008 - Spectrum Pharmaceuticals, Inc., (NasdaqGM:SPPI) announced today that an overview of the Company's business strategy will be presented at the JMP Securities Focus on Healthcare conference on Tuesday, October 7, 2008, at 10:00 a.m. Eastern/7:00...
Cytori Receives Key Patent for its Cosmetic & Reconstructive Surgery Product
SAN DIEGO-(Business Wire)-September 30, 2008 - Cytori Therapeutics (NASDAQ: CYTX) today received U.S. Patent No. 7,429,488 (the '488 patent), which broadly protects the Company's Celution(R) System-based methods of generating adipose tissue-derived stem and regenerative cell-enhanced fat grafts...
ImmunoGen, Inc. Announces CEO Succession Plan
WALTHAM, Mass.-(Business Wire)-September 30, 2008 - ImmunoGen, Inc. (Nasdaq: IMGN) today announced that Daniel M. Junius, currently President and Chief Operating Officer (COO) of the Company, will become President and Chief Executive Officer (CEO) effective January 1, 2009 in accordance with a...
EPIX Pharmaceuticals to Present at the 2008 Maxim Group Growth Conference
LEXINGTON, Mass.-(Business Wire)-September 30, 2008 - EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it...
A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
REDWOOD CITY, Calif.-(Business Wire)-September 30, 2008 - A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, announced today positive results from its pivotal Phase 3 study comparing the efficacy of APF530 (the Company's proprietary, sustained release formulation of granisetron...
Fondation IPSEN: "Cell Shape and Polarity: Lymphocytes and Beyond"
PARIS-(Business Wire)-September 30, 2008 - La Fondation IPSEN and Nature Publishing Group share the same desire to help new scientific knowledge emerge and facilitate the exchange of the most promising ideas from a variety of different research areas. In 2007, the two organisations came together...
Q-Med Terminates Collaboration With Medy-Tox Inc.
STOCKHOLM, Sweden-(Business Wire)-September 30, 2008 - Regulatory News: Q-Med AB and Medy-Tox Inc., a pharmaceuticals company based in South Korea, have together decided to terminate the collaboration that the parties entered into during 2007. The collaboration comprised the development and...
Elan Announces Dates for Upcoming Corporate Events
DUBLIN, Ireland-(Business Wire)-September 30, 2008 - Elan Corporation, plc (NYSE: ELN) today announced the dates for the following upcoming corporate events: Third Quarter 2008 Financial Results Elan will host a conference call on Thursday, October 23, 2008 at 8:30 a.m. Eastern Daylight Time...
Ipsen: FDA's First-Cycle Review of Dysport(R) to Be Completed by Year-End
PARIS-(Business Wire)-September 30, 2008 - Regulatory News: Ipsen (Paris:IPN) today announced that the U.S. Food and Drug Administration (FDA) provided notification that the Prescription Drug User Fee Act (PDUFA) action date for Dysport(R) (botulinum toxin of type A) Biologics License Application...
PharmaNet Development Group, Inc. to Announce Third Quarter 2008 Financial Results on October 29, 2008
PRINCETON, N.J.-(Business Wire)-September 29, 2008 - PharmaNet Development Group, Inc. (the "Company") (NASDAQ: PDGI), a leading provider of clinical development services, today announced that it will release its third quarter 2008 financial results on Wednesday, October 29, 2008, after market...
Medidata Solutions to Deliver Valuable Insights at Clinical Conferences in October
NEW YORK-(Business Wire)-September 29, 2008 - Medidata Solutions, a leading provider of clinical trial solutions, today announced that members of its management team will present at four industry events in October: -0- *T Marcus Evans Conference on Optimizing Clinical Trials October 2-3, 2008...
AlloSource Recognized as Top Innovator at 2008 "Champions in Healthcare" Awards
CENTENNIAL, Colo.-(Business Wire)-September 29, 2008 - AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, announced today that its President and CEO, Thomas A. Cycyota, has been selected as the Healthcare Innovator of...
Cubist Pharmaceuticals Opens New Research Facility at Lexington Headquarters
LEXINGTON, Mass.-(Business Wire)-September 29, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today opened a new, state-of-the-art, 35,000 square foot research facility at the company's headquarters. The laboratory will accommodate more than 100 employees focused on the discovery of important...
Charles River Announces Promotion of Dr. Christophe Berthoux as Major Step in Realignment of Its Global Sales and Marketing Organization
WILMINGTON, Mass.-(Business Wire)-September 29, 2008 - Charles River Laboratories International, Inc. (NYSE: CRL) announced today the promotion of Dr. Christophe Berthoux to the newly-created position of Executive Vice President, Global Sales and Marketing and Chief Commercial Officer. In this role...
AtriCure to Participate at the Third Annual JMP Securities Healthcare Focus Conference in October
WEST CHESTER, Ohio-(Business Wire)-September 29, 2008 - AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that David J. Drachman, President and Chief Executive Officer, is scheduled to present at the Third Annual JMP Securities...
Covidien CEO Elected Chairman of the Board
HAMILTON, Bermuda-(Business Wire)-September 29, 2008 - Covidien Ltd. (NYSE: COV, BSX: COV) today announced that its Board of Directors has elected CEO and President Richard J. Meelia to the additional position of Chairman of the Board, effective October 1, 2008. Mr. Meelia succeeds Dennis H...
National Cancer Institute Selects CambridgeSoft to Support Chemical Biology Consortium
CAMBRIDGE, Mass.-(Business Wire)-September 29, 2008 - The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice...
The Addario Lung Cancer Medical Institute (ALCMI) Names Steven W. Young, President
SAN FRANCISCO, Calif.-(Business Wire)-September 29, 2008 - The Addario Lung Cancer Medical Institute (ALCMI) today announced the appointment of Steven W. Young to the position of president. In this role, Young will develop organizational strategy and provide leadership, vision, and direction. Tony...
Array BioPharma to Present at the William Blair Small-Cap Growth Stock Conference
BOULDER, Colo.-(Business Wire)-September 29, 2008 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the William Blair Small-Cap Growth Stock Conference on October 7 in New York City. The public is welcome to participate in the...
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
EDISON, N.J.-(Business Wire)-September 29, 2008 - Oceana Therapeutics, Inc., a newly founded specialty pharmaceutical company announced the closing of its Series A preferred stock financing and the commencement of operations. Oceana will acquire drugs and devices targeted at select medical...
Bio-Imaging Technologies Appoints Peter S. Benton President of Its Phoenix Data Systems Division
NEWTOWN, Pa.-(Business Wire)-September 29, 2008 - Bio-Imaging Technologies, Inc. ("Bio-Imaging") (NASDAQ: BITI) today announced that it has appointed Peter S. Benton as President of its Phoenix Data Systems ("PDS") Division. PDS is a leading global clinical data services provider of electronic...
Companies and Markets: "The Fastest Growing Biotechnology Companies" Market Report Available Now
LONDON-(Business Wire)-September 29, 2008 - Companies and Markets announces the addition of "The Fastest Growing Biotechnology Companies - Growth strategies, comparative analyses and company profiles" market research report to its portfolio In recent years, the biopharmaceutical industry has emerged...
Bio-Quant Announces the Expansion of Its Research Animal Diagnostic Services to Cover All Nine Species
SAN DIEGO-(Business Wire)-September 29, 2008 - Bio-Quant, Inc. ("Bio-Quant") (OTC: BQNT.PK), the largest biotech Contract Research Organization (CRO) in San Diego, announced today the expansion of its animal diagnostic services division to cover all nine species used in research. Dr. Bassam Damaj...
Stratatech Successfully Completes Clinical Trial of StrataGraft(R) Skin Substitute
MADISON, Wis.-(Business Wire)-September 29, 2008 - Stratatech Corp., a regenerative medicine company focused on the development and commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has successfully completed the multi-center, 15-patient clinical...
New York Biotechnology Association and New York Academy of Sciences Launch Joint Membership Alliance for Emerging Biotech Companies
NEW YORK-(Business Wire)-September 29, 2008 - The New York Biotechnology Association (NYBA) and the New York Academy of Sciences (NYAS) today announced an alliance designed to give emerging biotech companies reduced price access to NYAS corporate membership. The new 'Growth Partners' program will...
Orthofix Successfully Amends Credit Facility
BOSTON-(Business Wire)-September 29, 2008 - Orthofix International N.V. (NASDAQ: OFIX) (the Company), Orthofix Holdings Inc. and certain subsidiaries of the Company announced today that they have completed the first amendment to their existing credit agreement dated September 22, 2006. The...
AxioMed Spine Corporation Initiates Pivotal Study
GARFIELD HEIGHTS, Ohio-(Business Wire)-September 29, 2008 - AxioMed(R) Spine Corporation (www.axiomed.com), focused on next-generation devices for the restoration of spinal function, announces the initiation of its pivotal clinical study of the Freedom(R) Lumbar Disc, an elastomeric total disc...
Candela to Present at Maxim Growth Conference October 7, 2008
WAYLAND, Mass.-(Business Wire)-September 29, 2008 - Candela Corporation (NASDAQ:CLZR) announced today that its President & CEO, Gerard E. Puorro, will present at the Maxim Group Growth Conference in New York City on Tuesday, October 7, 2008 at 9:30 a.m. EDT. In addition, Mr. Puorro will...
ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2008
SAN DIEGO-(Business Wire)-September 29, 2008 - ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will present at...
Protein'eXpert Changes Its Name to PX'Therapeutics
GRENOBLE, France-(Business Wire)-September 29, 2008 - Protein'eXpert SA today announced that it has changed its name to PX'Therapeutics. The new name builds on an already strong European position as a Contract Research and Manufacturing Organization specialised in the development of recombinant...
Dynavax Awarded $17 Million Contract from National Institutes of Health
BERKELEY, Calif.-(Business Wire)-September 29, 2008 - Dynavax Technologies Corporation (NASDAQ:DVAX) today announced it has been awarded a $17 million contract to develop its advanced immunostimulatory sequences (ISS) technology using Toll-Like Receptor 9 (TLR9) agonists as vaccine adjuvants. This...
Ultraviolet Water Treatment Systems Becoming the Solution for More Consumers at eWaterOnline.net
FREDERICK, Pa.-(Business Wire)-September 29, 2008 - Ultraviolet water treatment systems are becoming the solution for more and more online consumers each month at popular water softener and water treatment destination eWaterOnline.net, a division of CAI Technologies. Historically used for...
Blood Cell Storage and CaridianBCT Sign Option Agreement
SEATTLE-(Business Wire)-September 29, 2008 - Blood Cell Storage, Inc., Seattle WA, announces that it has signed an option agreement to supply pH testing inserts to CaridianBCT for manufacturing into platelet storage bags for their blood collection systems. Blood Cell Storage, Inc. (BCSI) has...
ImClone Systems Issues Statement
NEW YORK-(Business Wire)-September 29, 2008 - ImClone Systems Incorporated (NASDAQ: IMCL) announced today that the large Pharma company that had made an offer to acquire ImClone at $70 per share, subject to due diligence, but not financing, has informed ImClone that by 11:59 pm on Wednesday, October...
PPD Confirms Takeda's NDA Submission of Alogliptin in Japan
WILMINGTON, N.C.-(Business Wire)-September 29, 2008 - PPD, Inc. (NASDAQ:PPDI) today confirmed that Takeda Pharmaceutical Company Limited has submitted a new drug application for alogliptin, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, to the Ministry of Health, Labour and...
Dosing Initiated in TransMolecular's Phase 1/2 Clinical Trial for Intravenous Administration of (131)Iodine-TM601 in Patients with Recurrent Malignant Glioma
CAMBRIDGE, Mass.-(Business Wire)-September 29, 2008 - TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, announced today that dosing was initiated in a Phase 1/2 trial of (131)I-TM601 delivered intravenously (IV) for the treatment of adult patients with recurrent...
AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics
NEEDHAM, Mass.-(Business Wire)-September 29, 2008 - AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) (the "Company"), today announced that, pursuant to a previously announced shareholder vote, the Company will change its name to Celldex Therapeutics, Inc. effective October 1, 2008 and shares of the...
Micronics Receives Two New Patents on Microfluidic Technologies
REDMOND, Wash.-(Business Wire)-September 29, 2008 - Micronics, Inc. today announced that it has been issued two patents from the United States Patent and Trademark Office (USPTO) for novel microfluidic devices and methods. These new patents relate to the company's focus on the development of rapid...
Sun Pharma Chooses FEI Solution for Nanoparticle Research at Advanced Centre in India
HILLSBORO, Ore.-(Business Wire)-September 29, 2008 - FEI Company (Nasdaq: FEIC), a leading provider of high-resolution imaging and analysis systems, announced today the installation of a solution based upon FEI's Tecnai(TM) Spirit cryo-transmission electron microscope (TEM) and three-dimensional...
Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis
SANTA CLARA, Calif.-(Business Wire)-September 29, 2008 - Affymetrix Inc. (NASDAQ:AFFX) today announces the GeneTitan(TM) System, the only complete platform to automate customer workflow from target preparation through array processing and data analysis, which maximizes data reproducibility, user...
VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and Type 1 Diabetes
BLUE BELL, Pa.-(Business Wire)-September 29, 2008 - VGX Pharmaceuticals, a biopharmaceutical company that is developing DNA vaccines for cancer and HIV and therapeutics for other diseases, announced today the results of a Phase I single ascending dose (SAD) study that demonstrated that its lead...
ZIOPHARM Oncology to Present at the Third Annual JMP Securities Healthcare Focus Conference
NEW YORK-(Business Wire)-September 29, 2008 - ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, Chief Executive Officer, will present at the Third Annual JMP Securities Healthcare Focus Conference on Monday, October 6, 2008 at 3:30 at Le Meridien Hotel in New York...
Search Our News Using Google Search
Can't find what you want? Try using Google:
